Suppr超能文献

25-27G混合式玻璃体切除术联合同轴2.2毫米小切口白内障手术的手术及功能结果

Surgical and Functional Results of Hybrid 25-27-Gauge Vitrectomy Combined with Coaxial 2.2 mm Small Incision Cataract Surgery.

作者信息

Höhn Fabian, Kretz Florian, Pavlidis Mitrofanis

机构信息

Helios Klinikum Pforzheim, Kanzlerstraße 2-6, 75175 Pforzheim, Germany.

Augenklinik Ahaus, Am Schloßgraben 13, 48683 Ahaus, Germany.

出版信息

J Ophthalmol. 2016;2016:9186351. doi: 10.1155/2016/9186351. Epub 2016 Feb 4.

Abstract

Purpose. To investigate outcomes after coaxial 2.2 mm small incision cataract surgery combined with hybrid 25-27-gauge vitrectomy in eyes with vitreoretinal disease and age-related cataract. Methods. A single-center, retrospective case series study of 55 subjects (55 eyes) with a mean age of 70 years who underwent combined small incision phacoemulsification, intraocular lens (IOL) implantation, and hybrid 25-27-gauge vitrectomy during the 12-month period to December 2014. Intraoperative and postoperative complications and visual results were the main outcome measures. Results. The mean follow-up period was 6 months (range: 2-18 months). Intraoperative findings were 3 retinal breaks (5.5%). No cases required corneal or scleral suture or conversion to larger-gauge vitrectomy. Postoperative complications consisted of posterior capsule opacification (12.7%), elevated intraocular pressure >30 mmHg (1.8%), and fibrin reaction (5.5%). There were no cases of hypotony (<7 mmHg), IOL decentration, or postoperative endophthalmitis. Visual acuity (mean ± SD) improved from 0.52 ± 0.6 logMAR preoperatively to 0.22 ± 0.46 logMAR at final postoperative visit (P < 0.0001). Conclusion. Surgical and visual outcomes suggest hybrid 25-27-gauge vitrectomy combined with small incision phacoemulsification and IOL implantation is feasible, safe, and effective as a one-step surgical procedure for the management of vitreoretinal pathologies and concurrent cataract.

摘要

目的。探讨同轴2.2毫米小切口白内障手术联合25 - 27号混合玻璃体切除术治疗伴有玻璃体视网膜疾病和年龄相关性白内障患者的疗效。方法。一项单中心回顾性病例系列研究,纳入55例(55只眼)平均年龄70岁的患者,这些患者在2014年12月前的12个月期间接受了小切口超声乳化白内障吸除术、人工晶状体(IOL)植入术和25 - 27号混合玻璃体切除术。术中及术后并发症和视力结果为主要观察指标。结果。平均随访期为6个月(范围:2 - 18个月)。术中发现3例视网膜裂孔(5.5%)。无一例需要角膜或巩膜缝合或转为更大切口的玻璃体切除术。术后并发症包括后囊膜混浊(12.7%)、眼压升高>30 mmHg(1.8%)和纤维蛋白反应(5.5%)。无低眼压(<7 mmHg)、人工晶状体偏心或术后眼内炎病例。视力(平均值±标准差)从术前的0.52±0.6 logMAR提高到术后末次随访时的0.22±0.46 logMAR(P < 0.0001)。结论。手术及视力结果表明,25 - 27号混合玻璃体切除术联合小切口超声乳化白内障吸除术及人工晶状体植入术作为一种一步手术方法治疗玻璃体视网膜病变及并发白内障是可行、安全且有效的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99a3/4757709/998b68994b5f/JOPH2016-9186351.001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验